Form 4: TransMedics Executive Sells Shares for Tax Obligations

TransMedics Group SVP Nicholas Corcoran disposed of common stock to cover tax obligations related to restricted stock unit vesting.

Summary

• Nicholas Corcoran, SVP of Supply Chain and Operations at TransMedics Group, Inc., reported two dispositions of common stock.
• On January 23, 2026, 984 shares were withheld by the Issuer at a price of $135.3 per share to satisfy tax withholding obligations related to restricted stock unit vesting.
• Following this transaction, Corcoran beneficially owned 32,797 shares of common stock.
• On March 2, 2026, an additional 2,966 shares were sold at $139.12 per share to cover further tax withholding obligations from restricted stock unit vesting, executed as a "sell to cover" transaction.
• After the second transaction, Corcoran's direct beneficial ownership stands at 29,831 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The transactions are routine tax-related dispositions of shares from RSU vesting and do not reflect a change in the executive's investment sentiment or the company's operational performance.

Positives

• The transactions are routine and related to the vesting of restricted stock units, indicating compensation for the executive.
• The sales were executed at prices of $135.3 and $139.12, reflecting the company's stock value at the time of vesting/sale.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that 'sell to cover' transactions and share withholdings for tax obligations upon restricted stock unit vesting are standard practices for executive compensation in publicly traded companies. These transactions are generally not indicative of a change in management's confidence in the company's future prospects but rather a routine part of managing equity compensation.

Stakeholder Impact

• Shareholders: Minimal direct impact as these are routine tax-related sales and do not signal a change in company fundamentals or executive confidence. The number of shares is relatively small compared to total outstanding shares.

Key Dates

Recommendation

This Form 4 filing details routine, non-discretionary sales of TransMedics Group common stock by an executive to cover tax obligations associated with restricted stock unit vesting. Such transactions are standard practice for executive compensation and do not typically signal a change in the company's fundamental outlook or the executive's long-term confidence. Therefore, the filing itself does not provide new information that would warrant a change in an investor's existing position, leading to a 'hold' recommendation.

Keywords

TransMedics Group, TMDX, Nicholas Corcoran, Form 4, Insider Trading, Stock Sale, Restricted Stock Units, Tax Withholding, Executive Compensation, Officer Transaction